SOAT1 and cancer: The genetic silencing of SOAT1/ACAT1 or the pharmacologic blocking of its activity suppresses tumor growth in several cancer xenograft models (Bemlih et al., 2010; Ohmoto et al., 2015; Geng et al., 2016; LaPensee et al., 2016).